DAIC Articles

Feb 15, 2018 | DAIC Articles
Abiomed Receives Expanded Impella Approval for Cardiomyopathy With Cardiogenic Shock

“Abiomed Inc. announced that it received an expanded U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella 2.5, Impella CP, Impella 5.0 and Impella LD heart pumps to provide treatment for heart failure associated with cardiomyopathy leading to cardiogenic shock.”

Feb 14, 2018 | DAIC Articles
FDA Expands Impella Indication for High-risk PCI Procedures

“Abiomed Inc. announced it received an expanded U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella 2.5 and Impella CP heart pumps for use during elective and urgent high-risk percutaneous coronary intervention (PCI) procedures.”

Feb 13, 2018 | DAIC Articles
Abbott Begins Enrollment in XIENCE 28 GLOBAL DAPT Trial

“Abbott announced the first patient has been enrolled in a clinical trial evaluating 28 days of dual antiplatelet therapy (DAPT) in patients at high risk of bleeding after implantation with a Xience everolimus-eluting coronary stent.”

Feb 7, 2018 | DAIC Articles
Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares

“Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch of new versions of its Expro Elite and Sympro Elite Snares for manipulating interventional devices in peripheral procedures.”

Feb 7, 2018 | DAIC Articles
Recently Introduced Angiography Imaging Technology

“Five new angiography systems were launched in 2017 that included improvements to speed workflow and improve both image quality and interventional procedural guidance.”

Feb 7, 2018 | DAIC Articles
In.Pact Admiral Balloon Demonstrates Consistent, Durable Outcomes in LINC 2018 Studies

“Medtronic plc recently added to its body of clinical evidence supporting the In.Pact Admiral drug-coated balloon (DCB) with new presentations that demonstrated durable and consistent clinical outcomes in peripheral artery disease (PAD).”

Feb 5, 2018 | DAIC Articles
Most Popular Cardiology Technology Content in January 2018 on DAIC

“Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2018. This is based on website analytics of the month’s 139,874 pageviews:”

Feb 5, 2018 | DAIC Articles
A Thoracic Endovascular Aortic Repair (TEVAR) Stent Graft Buyer’s Guide

“Here are several considerations for physicians when choosing endovascular stent grafts used to treat aortic aneurysms. Multiple devices are available on the market, each with unique features.”

Feb 1, 2018 | DAIC Articles
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status

“LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), announced the completion of enrollment of the original 10-patient cohort in the U.S. feasibility study of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System.”

Feb 1, 2018 | DAIC Articles
Study Shows Embotrap Device Usage During Stroke Treatment Yields Positive Rates Revascularization

“EmboTrap Device, a device designed to remove clots from the brain following an ischemic stroke, demonstrated high success rates in restoring blood flow and patients achieved high rates of functional independence, according to ARISE II (Analysis of Revascularization in Ischemic Stroke with EmboTrap Device), a new clinical trial presented at the American Stroke Association’s (ASA) International Stroke Conference 2018.”

X